Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The main objective of the SPARX trial is to compare paclitaxel-coated balloons to with contemporary DES in complex and small coronary artery lesions in patients with NSTEACS or CCS; the co-primary objective is to compare two different paclitaxel-coated balloons, Protégé and Agent, with each other.
Epistemonikos ID: c75b73692d398a35fe5e526ba08d3223175008b9
First added on: Feb 10, 2026